Q: I would appreciate your updated view of Baylin. Does the recent filing of a "Preliminary Base Shelf Prospectus" indicate that there will likely be further equity dilution?
Q: Hi, can you please analyze rti, radient technologies. They have an interesting exposure to the cannabis industry and perhaps a good way to play it. Please provide info on future revenue growth and thoughts on technology. Thanks.
Q: I bought NMX in 2015 at .36 and sold it in 2016 for 1.84 then bought it back again at $1.09. It is up 60% since July. With today's surge it has reached 10% of my portfolio. Again. But compared with similar projects it is undervalued (ie Mason LLG.X that is at 2.25 and is no where near starting production). My dilemma is do I hold on or take profit. I am well diversified and going to retire in 60 days.
Can you provide an opinion of the potential of this little company please? As a tiny, pre-revenue? company I expect they aren't even close to being on your radar but it's the concept and/or target industry niche that has me questioning whether there is potential and worthy of monitoring them for a while.
Thank you
Mike
Q: Peter and His Wonder Team
GCL just reported a 3rd Q. miss and the stock has crashed 25%. Please give your assessment of this company...especially there financial strength...debt vs. cash on hand. Do you think they qualify as a contrarian play or are the risks just too high. Also since the 4th Q. appears poor do you think they are vulnerable to tax loss selling?
Thanks for your consistent excellence...
Dr.Ernest Rivait
Q: Mixed feelings about IPA
Very promissing (I think and could be wrong!)
Stock behaviour brutal and impredictable
Your opinion will be appreciated
CDJ
Q: Good morning doing some house cleaning pre-tax loss season. I had half positions in the above firms and sold same this morning. Original investment $10K. 44% loss in CRH, 20% loss in GPS &26% approx. loss in ITC. I have full positions in GUD,TOY,SIS,GSY, PBH,NFI,KXS,1/2 position in PHO. My question do I wait and buy back the 3 sold or allocate the cash to the above names with momentum; and if so how would you suggest I allocate the funds.Thanks in advance david P.S. 15 blue chip names back up these small caps; banks ;utilities; pipelines and telecoms.
Q: Hi Peter and team:
Two of the companies in my small cap portfolio, Acuity
Ads and TSO3, have performed badly for me in the last year. I am down 50% on AT and down 40% on TSO. I am willing to be patient but wondering if this is a recovery that could take many months, if not years, which is too long for me. Do I hang on, or are there other small cap stocks with promising technologies that may be preferable with a shorter timeline to success? By the way, I own PHO after reading your reviews, which has worked out well for me, thanks.
Pierre
Q: I have noticed that Questor's stock is hitting 52-week highs and the average trading volumes are on the rise over the last 3 months. Given its seller financial results year-to-date, rising market cap and strong balance sheet and its clean tech business, do you think the stock will get more attention again from bigger investors like it once had?
Q: They seem to have bottomed out and are now moving up on increased volume
Would this be a time to enter a small position
Tfsa and ok with risk
Thank you
Q: Marijuana, marijuana, marijuana. I grew up in Saskatchewan and knew very few rich farmers. Is there some reason why farming marijuana is going to be so much more profitable than growing canola?
Q: What are your thoughts on the above three companies? Seems like everyone (even novice investors) are jumping on the band wagon bragging how much they made to date which has made me a bit uneasy. I have no exposure in the sector. Take out 3 credits if required.